Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pharmacology & Therapeutics|January 4, 2014
Epigenetic drugs as immunomodulators for combination therapies in solid tumorsLuca Sigalotti, Elisabetta Fratta, Sandra Coral, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNALuca Sigalotti, Alessia Covre, Francesca Colizzi, et al.
Oncogene|October 7, 2003
Epigenetic targets for immune intervention in human malignanciesMichele Maio, Sandra Coral, Elisabetta Fratta, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Epigenetic markers of prognosis in melanomaLuca Sigalotti, Elisabetta Fratta, Giulia Parisi, et al.
Clinical Epigenetics|December 7, 2017
Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factorsPaolo Boscolo-Rizzo, Carlo Furlan, Valentina Lupato, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 2, 2021
Long Noncoding RNAs as Innovative Urinary Diagnostic BiomarkersGiulia Brisotto, Roberto Guerrieri, Francesca Colizzi, et al.
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Oncotarget|June 23, 2016
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesElisabetta Fratta, Barbara Montico, Aurora Rizzo, et al.
Cancers|May 13, 2023
Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint InhibitorsElena Muraro, Lorenzo Vinante, Elisabetta Fratta, et al.
Cell Communication and Signaling : CCS|April 9, 2025
Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunitiesArianna Bellazzo, Barbara Montico, Roberto Guerrieri, et al.
Pageof 4